U.S. FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama's fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes
You may also be interested in...
Global GMPs: How Much Faith Will U.S. FDA Put In Private Third-Party Audits?
Private and third-party audits may not replace U.S. FDA's typical inspection duties, but could help direct the agency to problematic facilities and relieve some of the inspection burden on those that already are compliant
Global GMPs: How Much Faith Will U.S. FDA Put In Private Third-Party Audits?
Private and third-party audits may not replace U.S. FDA's typical inspection duties, but could help direct the agency to problematic facilities and relieve some of the inspection burden on those that already are compliant
FDA's Competing Budget Aims: Frugality Versus Launching New Initiatives
FDA's proposed fiscal year 2012 budget provides a modest 7% increase in federal appropriations for the human drugs program, which also will benefit from a hefty 46% increase in PDUFA user fees.